These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 25637348)

  • 21. Hepatitis C virus (HCV): a review of immunological aspects.
    Irshad M; Khushboo I; Singh S; Singh S
    Int Rev Immunol; 2008; 27(6):497-517. PubMed ID: 19065353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization and role of intra-hepatic regulatory T cells in chronic hepatitis C pathogenesis.
    Sturm N; Thélu MA; Camous X; Dimitrov G; Ramzan M; Dufeu-Duchesne T; Bonorino P; Guillermet C; Brambilla E; Arvers P; Pernollet M; Leroy V; Zarski JP; Marche PN; Jouvin-Marche E
    J Hepatol; 2010 Jul; 53(1):25-35. PubMed ID: 20452085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for a relation between the viral load and genotype and hepatitis C virus-specific T cell responses.
    Hultgren C; Desombere I; Leroux-Roels G; Quiroga JA; Carreno V; Nilsson B; Weiland O; Sällberg M
    J Hepatol; 2004 Jun; 40(6):971-8. PubMed ID: 15158338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD45RA and CD45RO isoform expression on intrahepatic T-lymphocytes in chronic hepatitis C.
    Fiore G; Galetta V; Piazzolla G; Angarano I; Jirillo E; Schiraldi O; Antonaci S
    Microbios; 1997; 92(371):73-82. PubMed ID: 9589606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intrahepatic hepatitis C virus-specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis C.
    Nelson DR; Marousis CG; Ohno T; Davis GL; Lau JY
    Hepatology; 1998 Jul; 28(1):225-30. PubMed ID: 9657116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The potential use of Toll-like receptor agonists to restore the dysfunctional immunity induced by hepatitis C virus.
    Salem ML; El-Demellawy M; El-Azm AR
    Cell Immunol; 2010; 262(2):96-104. PubMed ID: 20338549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential antigen specificity of hepatitis C virus-specific interleukin 17- and interferon γ-producing CD8(+) T cells during chronic infection.
    Grafmueller S; Billerbeck E; Blum HE; Neumann-Haefelin C; Thimme R
    J Infect Dis; 2012 Apr; 205(7):1142-6. PubMed ID: 22351943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection.
    Boettler T; Spangenberg HC; Neumann-Haefelin C; Panther E; Urbani S; Ferrari C; Blum HE; von Weizsäcker F; Thimme R
    J Virol; 2005 Jun; 79(12):7860-7. PubMed ID: 15919940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FOXP3 expression in hepatitis C virus-specific CD4+ T cells during acute hepatitis C.
    Heeg MH; Ulsenheimer A; Grüner NH; Zachoval R; Jung MC; Gerlach JT; Raziorrouh B; Schraut W; Horster S; Kauke T; Spannagl M; Diepolder HM
    Gastroenterology; 2009 Oct; 137(4):1280-8.e1-6. PubMed ID: 19596013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD81 expression on CD19+ peripheral blood lymphocytes is associated with chronic HCV disease and increased risk for HCV infection: a putative role for inflammatory cytokines.
    D'Agosto G; Trento E; Nosotti L; Bordignon V; Battista M; Prignano G; Pimpinelli F; Biolcati G; Macrì A; Palamara G; Miglioresi L; Morrone A; Di Carlo A; Cordiali-Fei P; Ensoli F
    J Biol Regul Homeost Agents; 2009; 23(3):155-64. PubMed ID: 19828092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intrahepatic virus-specific IL-10-producing CD8 T cells prevent liver damage during chronic hepatitis C virus infection.
    Abel M; Sène D; Pol S; Bourlière M; Poynard T; Charlotte F; Cacoub P; Caillat-Zucman S
    Hepatology; 2006 Dec; 44(6):1607-16. PubMed ID: 17133491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adaptive immune responses in acute and chronic hepatitis C virus infection.
    Bowen DG; Walker CM
    Nature; 2005 Aug; 436(7053):946-52. PubMed ID: 16107834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD4⁺ and CD8⁺ regulatory T cells (Tregs) are elevated and display an active phenotype in patients with chronic HCV mono-infection and HIV/HCV co-infection.
    Hartling HJ; Gaardbo JC; Ronit A; Knudsen LS; Ullum H; Vainer B; Clausen MR; Skogstrand K; Gerstoft J; Nielsen SD
    Scand J Immunol; 2012 Sep; 76(3):294-305. PubMed ID: 22671952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Virus-specific CD4+ T cell responses in chronic HCV infection in blood and liver identified by antigen-specific upregulation of CD154.
    Mueller M; Spangenberg HC; Kersting N; Altay T; Blum HE; Klenerman P; Thimme R; Semmo N
    J Hepatol; 2010 Jun; 52(6):800-11. PubMed ID: 20416967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of cytokine gene polymorphism and hepatic transforming growth factor beta1 expression in recurrent hepatitis C after liver transplantation.
    Ben-Ari Z; Pappo O; Druzd T; Sulkes J; Klein T; Samra Z; Gadba R; Tambur AR; Tur-Kaspa R; Mor E
    Cytokine; 2004 Jul; 27(1):7-14. PubMed ID: 15207246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver-derived CTL in hepatitis C virus infection: breadth and specificity of responses in a cohort of persons with chronic infection.
    Wong DK; Dudley DD; Afdhal NH; Dienstag J; Rice CM; Wang L; Houghton M; Walker BD; Koziel MJ
    J Immunol; 1998 Feb; 160(3):1479-88. PubMed ID: 9570570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD8+ cell responses to hepatitis C virus (HCV) in the liver of persons with HCV-HIV coinfection versus HCV monoinfection.
    Alatrakchi N; Graham CS; He Q; Sherman KE; Koziel MJ
    J Infect Dis; 2005 Mar; 191(5):702-9. PubMed ID: 15688283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Present and future therapy for hepatitis C virus.
    Cornberg M; Deterding K; Manns MP
    Expert Rev Anti Infect Ther; 2006 Oct; 4(5):781-93. PubMed ID: 17140355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cleavage of the T cell protein tyrosine phosphatase by the hepatitis C virus nonstructural 3/4A protease induces a Th1 to Th2 shift reversible by ribavirin therapy.
    Brenndörfer ED; Brass A; Karthe J; Ahlén G; Bode JG; Sällberg M
    J Immunol; 2014 Feb; 192(4):1671-80. PubMed ID: 24442435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory molecules that regulate expansion and restoration of HCV-specific CD4+ T cells in patients with chronic infection.
    Raziorrouh B; Ulsenheimer A; Schraut W; Heeg M; Kurktschiev P; Zachoval R; Jung MC; Thimme R; Neumann-Haefelin C; Horster S; Wächtler M; Spannagl M; Haas J; Diepolder HM; Grüner NH
    Gastroenterology; 2011 Oct; 141(4):1422-31, 1431.e1-6. PubMed ID: 21763239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.